Correlation Between Aquestive Therapeutics and Carmell Therapeutics
Can any of the company-specific risk be diversified away by investing in both Aquestive Therapeutics and Carmell Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aquestive Therapeutics and Carmell Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aquestive Therapeutics and Carmell Therapeutics, you can compare the effects of market volatilities on Aquestive Therapeutics and Carmell Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aquestive Therapeutics with a short position of Carmell Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aquestive Therapeutics and Carmell Therapeutics.
Diversification Opportunities for Aquestive Therapeutics and Carmell Therapeutics
-0.28 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Aquestive and Carmell is -0.28. Overlapping area represents the amount of risk that can be diversified away by holding Aquestive Therapeutics and Carmell Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Carmell Therapeutics and Aquestive Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aquestive Therapeutics are associated (or correlated) with Carmell Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Carmell Therapeutics has no effect on the direction of Aquestive Therapeutics i.e., Aquestive Therapeutics and Carmell Therapeutics go up and down completely randomly.
Pair Corralation between Aquestive Therapeutics and Carmell Therapeutics
Given the investment horizon of 90 days Aquestive Therapeutics is expected to under-perform the Carmell Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Aquestive Therapeutics is 10.62 times less risky than Carmell Therapeutics. The stock trades about -0.17 of its potential returns per unit of risk. The Carmell Therapeutics is currently generating about 0.18 of returns per unit of risk over similar time horizon. If you would invest 28.00 in Carmell Therapeutics on October 25, 2024 and sell it today you would earn a total of 18.00 from holding Carmell Therapeutics or generate 64.29% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Aquestive Therapeutics vs. Carmell Therapeutics
Performance |
| Timeline |
| Aquestive Therapeutics |
| Carmell Therapeutics |
Aquestive Therapeutics and Carmell Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Aquestive Therapeutics and Carmell Therapeutics
The main advantage of trading using opposite Aquestive Therapeutics and Carmell Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aquestive Therapeutics position performs unexpectedly, Carmell Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Carmell Therapeutics will offset losses from the drop in Carmell Therapeutics' long position.| Aquestive Therapeutics vs. Evoke Pharma | Aquestive Therapeutics vs. Dynavax Technologies | Aquestive Therapeutics vs. Amphastar P | Aquestive Therapeutics vs. Lantheus Holdings |
| Carmell Therapeutics vs. American Airlines Group | Carmell Therapeutics vs. Li Auto | Carmell Therapeutics vs. Ferrari NV | Carmell Therapeutics vs. Marine Products |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Other Complementary Tools
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |